Uy Ear
Stock Analyst at Mizuho
(0.82)
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
SRPT Sarepta Therapeutics | Maintains: Outperform | 85 40 | 20.74 | 92.86% | 6 | Jun 18, 2025 | |
ACAD ACADIA Pharmaceutica... | Maintains: Neutral | 20 23 | 22.93 | 0.31% | 11 | May 19, 2025 | |
TECX Tectonic Therapeutic | Maintains: Outperform | 51 85 | 19.81 | 329.08% | 2 | May 15, 2025 | |
ARQT Arcutis Biotherapeut... | Maintains: Outperform | 20 21 | 13.65 | 53.85% | 14 | Feb 26, 2025 | |
QURE uniQure | Maintains: Neutral | 7 20 | 15.12 | 32.28% | 4 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 23 1 | 0.68 | 47.06% | 1 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 35 40 | 29.32 | 36.43% | 5 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 18 16 | 9.13 | 75.25% | 2 | Jul 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 40 | 9.99 | 300.4% | 1 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 20 23 | 9.29 | 147.58% | 3 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 116 140 | 127.23 | 10.04% | 10 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 60 24 | n/a | n/a | 4 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 35 16 | n/a | n/a | 1 | Nov 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 4 3 | n/a | n/a | 2 | Aug 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 36 40 | 150.78 | -73.47% | 1 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 2 | n/a | n/a | 1 | Mar 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 10 | 1.75 | 471.43% | 1 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 5 3 | 1.08 | 177.78% | 2 | Mar 1, 2023 |